Sensenig Bethany bought KALV
October 1, 2025 · Form 4 insider transaction
Sensenig Bethany bought 45,000 shares of KalVista Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderSensenig Bethany
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 2, 2025
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests over a 3-year period: 1/36th vests on November 1, 2025, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.